236 related articles for article (PubMed ID: 6951632)
21. Hodgkin's disease terminating in acute myeloid leukaemia.
Mauri C; Quaglino D
Haematologica; 1974 Mar; 59(1):86-90. PubMed ID: 4213144
[No Abstract] [Full Text] [Related]
22. Secondary neoplasms in malignant lymphomas after intensive therapy.
Bonadonna G; De Lena M; Banfi A; Lattuada A
N Engl J Med; 1973 Jun; 288(23):1242-3. PubMed ID: 4512612
[No Abstract] [Full Text] [Related]
23. Hodgkin's disease terminating as acute leukaemia: case report and review of the literature.
Wakem CJ; Bennett JM
N Z Med J; 1972 Sep; 76(484):187-94. PubMed ID: 4508745
[No Abstract] [Full Text] [Related]
24. Leukemia and other cancers after radiotherapy and chemotherapy for Hodgkin's disease.
Boivin JF; Hutchison GB
J Natl Cancer Inst; 1981 Oct; 67(4):751-60. PubMed ID: 6944544
[No Abstract] [Full Text] [Related]
25. Epidemiological studies of anticancer drug carcinogenicity.
Kaldor JM; Day NE; Shiboski S
IARC Sci Publ; 1986; (78):189-201. PubMed ID: 3583390
[TBL] [Abstract][Full Text] [Related]
26. Risk of leukemia associated with the first course of cancer treatment: an analysis of the Surveillance, Epidemiology, and End Results Program experience.
Curtis RE; Hankey BF; Myers MH; Young JL
J Natl Cancer Inst; 1984 Mar; 72(3):531-44. PubMed ID: 6583439
[TBL] [Abstract][Full Text] [Related]
27. Carcinogenesis in Hodgkin's disease.
Colman M
Hematol Oncol; 1984; 2(1):2-4. PubMed ID: 6588020
[No Abstract] [Full Text] [Related]
28. Acute myelogenous leukaemia following cytotoxic therapy: five cases and a review.
Smith AG; Prentice AG; Lucie NP; Browning JD; Dagg JH; Rowan RM
Q J Med; 1982; 51(202):227-40. PubMed ID: 6955825
[TBL] [Abstract][Full Text] [Related]
29. Second malignant tumours in childhood Hodgkin's disease.
Jenkin D; Greenberg M; Fitzgerald A
Med Pediatr Oncol; 1996 Jun; 26(6):373-9. PubMed ID: 8614372
[TBL] [Abstract][Full Text] [Related]
30. Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease.
Mauch PM; Kalish LA; Marcus KC; Shulman LN; Krill E; Tarbell NJ; Silver B; Weinstein H; Come S; Canellos GP; Coleman CN
Cancer J Sci Am; 1995; 1(1):33-42. PubMed ID: 9166452
[TBL] [Abstract][Full Text] [Related]
31. [Simultaneous and successive neoplastic disease. Apropos of 18 cases of malignant diseases complicating the evolution of Hodgkin's disease].
Jacquillat C; Belpomme D; Weil M; Auclerc G; Teillet F; Weisgerber C; Tanzer J; Boiron M; Bernard J
Nouv Presse Med; 1973 Dec; 2(46):3089-92. PubMed ID: 4522824
[No Abstract] [Full Text] [Related]
32. Leukemia after chemotherapy of Hodgkin's disease.
Castro GA; Church A; Pechet L; Snyder LM
N Engl J Med; 1973 Jul; 289(2):103-4. PubMed ID: 4513796
[No Abstract] [Full Text] [Related]
33. Hodgkin's disease and acute leukemia. Report of eight cases and review of the literature.
Rosner F; Grünwald H
Am J Med; 1975 Mar; 58(3):339-53. PubMed ID: 1090158
[TBL] [Abstract][Full Text] [Related]
34. High-dose therapy and autologous hematopoietic stem-cell transplantation does not increase the risk of second neoplasms for patients with Hodgkin's lymphoma: a comparison of conventional therapy alone versus conventional therapy followed by autologous hematopoietic stem-cell transplantation.
Forrest DL; Hogge DE; Nevill TJ; Nantel SH; Barnett MJ; Shepherd JD; Sutherland HJ; Toze CL; Smith CA; Lavoie JC; Song KW; Voss NJ; Gascoyne RD; Connors JM
J Clin Oncol; 2005 Nov; 23(31):7994-8002. PubMed ID: 16204014
[TBL] [Abstract][Full Text] [Related]
35. Analysis of the risk of solid tumor following Hodgkin's disease.
Maurizi Enrici R; Anselmo AP; Osti MF; Santoro M; Tombolini V; Mandelli F; Biagini C
Haematologica; 1997; 82(1):57-63. PubMed ID: 9107084
[TBL] [Abstract][Full Text] [Related]
36. [Malignant lymphoma].
Streuli RA
Schweiz Rundsch Med Prax; 1981 May; 70(20):909-15. PubMed ID: 7015304
[No Abstract] [Full Text] [Related]
37. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
[TBL] [Abstract][Full Text] [Related]
38. Dexrazoxane-associated risk for secondary malignancies in pediatric Hodgkin's disease: a claim without compelling evidence.
Lipshultz SE; Lipsitz SR; Orav EJ
J Clin Oncol; 2007 Jul; 25(21):3179; author reply 3180. PubMed ID: 17634500
[No Abstract] [Full Text] [Related]
39. Hodgkin's disease: treatment and secondary neoplasms.
Kaiser HE
In Vivo; 1994; 8(5):733-6. PubMed ID: 7727720
[TBL] [Abstract][Full Text] [Related]
40. Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study.
Sacchi S; Marcheselli L; Bari A; Marcheselli R; Pozzi S; Luminari S; Lombardo M; Buda G; Lazzaro A; Gobbi PG; Stelitano C; Morabito F; Quarta G; Brugiatelli M
Haematologica; 2008 Mar; 93(3):398-404. PubMed ID: 18268277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
